2-218075256-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_198483.4(RUFY4):c.764G>T(p.Ser255Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000621 in 1,579,364 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_198483.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RUFY4 | NM_198483.4 | c.764G>T | p.Ser255Ile | missense_variant | 9/13 | ENST00000697321.1 | NP_940885.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RUFY4 | ENST00000697321.1 | c.764G>T | p.Ser255Ile | missense_variant | 9/13 | NM_198483.4 | ENSP00000513250 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000662 AC: 13AN: 196426Hom.: 0 AF XY: 0.0000571 AC XY: 6AN XY: 105022
GnomAD4 exome AF: 0.0000392 AC: 56AN: 1427072Hom.: 0 Cov.: 30 AF XY: 0.0000368 AC XY: 26AN XY: 706528
GnomAD4 genome AF: 0.000276 AC: 42AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2024 | The c.764G>T (p.S255I) alteration is located in exon 9 (coding exon 7) of the RUFY4 gene. This alteration results from a G to T substitution at nucleotide position 764, causing the serine (S) at amino acid position 255 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at